Q9F663 (BLKPC_KLEPN) Klebsiella pneumoniae
Carbapenem-hydrolyzing beta-lactamase KPC UniProtKBInterProInteractive Modelling
293 aa; Sequence (Fasta) ;
66 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
74 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal Structure of the KPC-2 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP) |
Heteromer P35804; | |||||
Assess | ||||||
Crystal Structure of the KPC-2 Beta-lactamase/Beta-lactamase inhibitor protein (BLIP) |
Heteromer P35804; | |||||
Assess | ||||||
Acyl-enzyme complex of cephalothin bound to deacylation mutant KPC-2 (E166Q) | homo-2-mer | 6×SO4; 6×GOL; 2×CEO; | ||||
Assess | ||||||
Apo KPC-2 beta-lactamase crystal structure at 1.15 Angstrom resolution | monomer | 4×SO4; 1×GOL; | ||||
Assess | ||||||
Apo KPC-2 N170A mutant at 1.20 A | monomer | 1×GOL; 4×SO4; | ||||
Assess | ||||||
Structure of KPC-2 bound to Vaborbactam at 1.25 A | monomer | 1×4D6; 4×SO4; 1×GOL; | ||||
Assess | ||||||
Structure of KPC-2 bound to QPX7728 at 1.30 A | monomer | 1×RM9; 1×QNA; 1×GOL; 2×SO4; | ||||
Assess | ||||||
Crystal structure of vaborbactam bound to KPC-2 | monomer | 1×4D6; 2×GOL; 5×SO4; | ||||
Assess | ||||||
Crystal structure of KPC-4 complexed with relebactam (16 hour soak) | monomer | 4×SO4; 1×JJT; 1×GOL; 1×MK7; | ||||
Assess | ||||||
Crystal structure of KPC-2 complexed with relebactam (16 hour soak) | monomer | 3×SO4; 1×GOL; 1×MK7; 1×JJT; | ||||
Assess | ||||||
Crystal structure of KPC-3 complexed with relebactam (16 hour soak) | monomer | 2×SO4; 1×GOL; 1×EOH; 1×MK7; 1×JJT; | ||||
Assess | ||||||
Crystal structure of VNRX-5133 (taniborbactam) bound to KPC-2 | monomer | 1×GOL; 1×KJK; 2×SO4; | ||||
Assess | ||||||
Crystal structure of KPC-3 | monomer | 5×SO4; 2×GOL; | ||||
Assess | ||||||
Acylenzyme complex of ceftazidime bound to deacylation mutant KPC-4 (E166Q) | monomer | 4×GOL; 1×CAZ; 5×SO4; | ||||
Assess | ||||||
Acyl-enzyme complex of ertapenem bound to deacylation mutant KPC-2 (E166Q) | monomer | 4×SO4; 1×GOL; 1×N9X; | ||||
Assess | ||||||
Acylenzyme complex of ceftazidime bound to deacylation mutant KPC-2 (E166Q) | monomer | 1×CAZ; 3×SO4; | ||||
Assess | ||||||
Crystal structure of KPC-2 with hydrolyzed faropenem (ring-open form) | monomer | 1×R0B; 2×GOL; 4×SO4; | ||||
Assess | ||||||
Crystal structure of KPC-4 complexed with relebactam (1 hour soak) | monomer | 8×SO4; 1×GOL; 1×MK7; | ||||
Assess | ||||||
Crystal structure of KPC-2 complexed with compound 1 | monomer | 2×TWB; 1×GOL; | ||||
Assess | ||||||
Crystal structure of deacylation mutant KPC-2 (E166Q) | monomer | 2×GOL; 6×SO4; 1×CL; | ||||
Assess | ||||||
Acylenzyme complex of cefotaxime bound to deacylation mutant KPC-2 (E166Q) | monomer | 2×GOL; 5×SO4; 1×CEF; | ||||
Assess | ||||||
Acyl-enzyme complex of meropenem bound to deacylation mutant KPC-2 (E166Q) | monomer | 1×GOL; 1×O2F; 4×SO4; | ||||
Assess | ||||||
Crystal structure of KPC-2 complexed with compound 6 | monomer | 3×GTV; 1×GOL; | ||||
Assess | ||||||
Acyl-enzyme complex of imipenem bound to deacylation mutant KPC-2 (E166Q) | monomer | 1×ID1; 1×HIW; 3×SO4; 2×GOL; | ||||
Assess | ||||||
Crystal structure of deacylation mutant KPC-4 (E166Q) | monomer | 4×SO4; 1×GOL; | ||||
Assess | ||||||
Crystal structure of KPC-4 | monomer | 3×SO4; 2×GOL; | ||||
Assess | ||||||
Acyl-enzyme complex of ampicillin bound to deacylation mutant KPC-2 (E166Q) | monomer | 1×AIX; 4×SO4; 1×GOL; | ||||
Assess | ||||||
Crystal structure of KPC-2 complexed with compound 2 | monomer | 1×FUJ; 1×GOL; | ||||
Assess | ||||||
Crystal structure KPC-2 beta-lactamase complexed with WCK 4234 by soaking | monomer | 1×C8Y; 1×CIT; 1×EDO; | ||||
Assess | ||||||
Crystal structure of KPC-2 complexed with compound 9 | monomer | 3×YKG; 1×GOL; | ||||
Assess | ||||||
Crystal structure KPC-2 beta-lactamase complexed with WCK 5153 by soaking | monomer | 1×C9D; 1×CIT; 5×EDO; | ||||
Assess | ||||||
Crystal structure of KPC-2 complexed with compound 3 | monomer | 1×VKE; 1×GOL; | ||||
Assess | ||||||
Crystal structure KPC-2 beta-lactamase complexed with WCK 5107 by soaking | monomer | 1×C8V; 3×CIT; 6×EDO; | ||||
Assess | ||||||
Crystal structure KPC-2 beta-lactamase complexed with WCK 5107 by co-crystallization | monomer | 2×SO4; 1×CL; 1×C8V; | ||||
Assess | ||||||
Crystal structure KPC-2 beta-lactamase complexed with WCK 4234 by co-crystallization | monomer | 1×C8Y; 1×SO4; 1×CL; 1×ACT; | ||||
Assess | ||||||
Crystal structure KPC-2 beta-lactamase complexed with WCK 5153 by co-crystallization | monomer | 1×CD7; 2×SO4; 1×CL; | ||||
Assess | ||||||
Crystal structure of indoline 9 with KPC-2 | monomer | 3×GOL; 1×M53; | ||||
Assess | ||||||
Crystal structure of the KPC-2 beta-lactamase complexed with hydrolyzed cefotaxime | monomer | 2×CE4; 1×GOL; | ||||
Assess | ||||||
Crystal structure of indoline 7 with KPC-2 | monomer | 1×M2I; | ||||
Assess | ||||||
Crystal structure of the KPC-2 beta-lactamase complexed with hydrolyzed faropenem | monomer | 1×SFR; 1×GOL; | ||||
Assess | ||||||
KPC-2 N170A mutant bound to hydrolyzed ampicillin at 1.65 A | monomer | 1×ZZ7; 1×GOL; | ||||
Assess | ||||||
Crystal structure of KPC-2 with compound 3 | monomer | 4×J84; 1×GOL; | ||||
Assess | ||||||
Crystal structure of KPC-2 with compound 6 | monomer | 3×1CE; 1×GOL; | ||||
Assess | ||||||
Crystal structure of D179Y KPC-2 beta-lactamase | monomer | |||||
Assess | ||||||
Crystal structure of D179N KPC-2 beta-lactamase in complex with vaborbactam | monomer | 1×4D6; 1×PO4; | ||||
Assess | ||||||
Crystal structure of KPC-2 with compound 7 | monomer | 1×N1G; 1×GOL; | ||||
Assess | ||||||
Crystal structure of KPC-2 beta-lactamase in complex with the S02030 boronic acid inhibitor | monomer | 1×ZXM; 3×SO4; | ||||
Assess | ||||||
KPC-2 N170A mutant bound to hydrolyzed imipenem at 2.05 A | monomer | 1×8YF; | ||||
Assess | ||||||
Crystal structure of KPC-2 beta-lactamase complexed with hydrolyzed EXW-1 | monomer | 4×SO4; | ||||
Assess | ||||||
Crystal structure of D179N KPC-2 beta-lactamase | monomer | 1×CIT; | ||||
Assess | ||||||
Crystal structure of the C-terminal deleted mutant of the class A carbapenemase KPC-2 at 1.23 angst… | monomer | 1×CIT; | ||||
Assess | ||||||
KPC-2 carbapenemase in complex with PSR3-226 | monomer | 1×SR3; 1×CIT; | ||||
Assess | ||||||
Crystal structure of KPC-2 with compound 9 | monomer | 3×O5E; 1×ACT; | ||||
Assess | ||||||
Crystal structure of KPC-2 S70G/T215P mutant with hydrolyzed imipenem | monomer | 1×8YF; | ||||
Assess | ||||||
Crystal structure of KPC-2 carbapenemase in complex with a phenyl boronic inhibitor. | monomer | 1×6YV; | ||||
Assess | ||||||
Crystal structure of the class A carbapenemase KPC-2 at 1.6 angstrom resolution | monomer | |||||
Assess | ||||||
Crystal structure of KPC-2 S70G/T215P mutant with hydrolyzed meropenem | monomer | 1×8YL; | ||||
Assess | ||||||
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001 | monomer | 1×BHU; 7×PEG; 2×ACY; | ||||
Assess | ||||||
Crystal structure of KPC-2 beta-lactamase complexed with avibactam | monomer | 1×CIT; 1×NXL; | ||||
Assess | ||||||
Crystal structure of KPC-2 S70G/T215P mutant with hydrolyzed imipenem | monomer | 1×8YF; | ||||
Assess | ||||||
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor WL-001 | monomer | 1×BX9; 1×ACT; 2×ACY; 2×PEG; | ||||
Assess | ||||||
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor MS23 | monomer | 1×BXU; | ||||
Assess | ||||||
Serine Beta-Lactamase KPC-2 in Complex with Dual MBL/SBL Inhibitor MS05 | monomer | 1×BX6; 1×PEG; 2×ACY; | ||||
Assess | ||||||
Crystal structure of KPC-2 in complex with (S)-2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)a… | monomer | 1×J00; 1×ACY; 1×PEG; 3×GOL; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE KPC-2 D179N VARIANT IN COMPLEX WITH RELEBACTAM (IMINE HYDROLYSIS INTERMEDI… | monomer | 1×YOZ; 1×PO4; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE KPC-2 D179N VARIANT IN COMPLEX WITH AVIBACTAM | monomer | 1×NXL; | ||||
Assess | ||||||
KPC-2 carbapenemase in complex with 3-NPBA | monomer | 1×NPB; | ||||
Assess | ||||||
Crystal structure of the deacylation deficient KPC-2 F72Y mutant | monomer | |||||
Assess | ||||||
KPC-2 CARBAPENEMASE IN COMPLEX WITH THE BORONIC ACID INHIBITOR MB_076 | monomer | 1×OC0; | ||||
Assess | ||||||
Structure of KPC-2 bound to RPX-7063 at 1.75A | monomer | 1×ZXQ; 2×EDO; | ||||
Assess | ||||||
Crystal structure of the KPC-2 carbapenemase | monomer | 1×BCN; | ||||
Assess | ||||||
Crystal structure of KPC-2 T215P mutant | monomer | 2×NA; | ||||
Assess | ||||||
Crystal Structure of KPC-2 with compound 2 | monomer | 1×LW0; | ||||
Assess | ||||||
KPC-2 F72Y mutant with acylated imipenem | monomer | 1×IM2; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6xd5.1.A | monomer | 0.92 | 99.66 | |||
Assess |